NASDAQ: ESLA
Estrella Immunopharma Inc Stock Ownership - Who owns Estrella Immunopharma?

Insider buying vs selling

Have Estrella Immunopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Cheng LiuCEO2026-08-25100,000$0.82
$81.50kBuy
Jiandong XuCFO2026-08-18100,000$0.82
$81.50kBuy
Jiandong XuChief Financial Officer2025-10-071,000$1.33
$1.33kBuy
Jiandong XuChief Financial Officer2025-09-221,000$1.16
$1.16kBuy
Jiandong XuChief Financial Officer2025-09-11100$1.04
$104.00Buy

1 of 1

ESLA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ESLA insiders and whales buy or sell their stock.

ESLA Shareholders

What type of owners hold Estrella Immunopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eureka Therapeutics Inc58.11%25,277,831$16.18MInsider
Jianwei Li5.52%2,399,490$1.54MInsider
Tradeup Acquisition Sponsor LLC2.63%1,145,760$733.29kInsider
Cheng Liu0.91%397,437$254.36kInsider
Jiandong Xu0.88%382,188$244.60kInsider
Hong Zhang0.55%240,481$153.91kInsider
Tao Jiang0.02%10,000$6.40kInsider
Weston Twigg0.02%10,000$6.40kInsider
James Long0.02%10,000$6.40kInsider
Armist0.01%3,975$2.54kInstitution

1 of 3

ESLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ESLA0.01%68.68%Net BuyingNet Buying
EVAX0.00%5.19%
QNTM0.01%0.00%
CVM0.01%52.55%Net BuyingNet Buying
IGC0.01%24.95%Net BuyingNet Buying

Estrella Immunopharma Stock Ownership FAQ

Who owns Estrella Immunopharma?

Estrella Immunopharma (NASDAQ: ESLA) is owned by 0.01% institutional shareholders, 68.68% Estrella Immunopharma insiders, and 31.31% retail investors. Eureka Therapeutics Inc is the largest individual Estrella Immunopharma shareholder, owning 25.28M shares representing 58.11% of the company. Eureka Therapeutics Inc's Estrella Immunopharma shares are currently valued at $16.13M.

If you're new to stock investing, here's how to buy Estrella Immunopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.